Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody

Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody

Abstract Objectives Effective antibody–drug conjugates (ADCs) provide potent targeted cancer therapies. CD83 is expressed on activated immune cells including B cells and is a therapeutic target for Hodgkin lymphoma. Our objective was to determine CD83 expression on non‐Hodgkin lymphoma (NHL) and its...

Full description

Bibliographic Details
Main Authors: Ziduo Li, Edward Abadir, Kenneth Lee, Candice Clarke, Christian E Bryant, Wendy Cooper, Geoffrey Pietersz, James Favaloro, Pablo A Silveira, Derek NJ Hart, Xinsheng Ju, Georgina J Clark
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Clinical & Translational Immunology
Subjects:
antibody–drug conjugate
CD83
immunotherapy
mantle cell lymphoma
NF‐κB
Online Access:https://doi.org/10.1002/cti2.1156

Internet

https://doi.org/10.1002/cti2.1156

Similar Items